Innoviva (INVA) Research & Development (2010 - 2026)

Innoviva (INVA) has 15 years of Research & Development data on file, last reported at $5.2 million in Q1 2026.

• Quarterly Research & Development rose 19.22% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.7 million (up 109.72% YoY) and the FY2025 annual result came in at $30.6 million, up 124.14% from the prior year.
• Research & Development slipped to $5.2 million in Q1 2026, from $26.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $31.6 million in Q3 2023 to a low of $2.6 million in Q2 2024.
• A 5-year average of $13.1 million and a median of $10.0 million in 2024 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2022 — Research & Development surged 36436.84% — and 2024, when it plunged 82.92%.
• Tracing INVA's Research & Development over 5 years: stood at $31.4 million in 2022, then grew by 0.38% to $31.6 million in 2023, then plunged by 68.36% to $10.0 million in 2024, then soared by 160.78% to $26.0 million in 2025, then sank by 79.88% to $5.2 million in 2026.
• The last three Research & Development figures came in at $5.2 million (Q1 2026), $26.0 million (Q3 2025), and $8.0 million (Q2 2025), per Business Quant data.